| Primary |
| Drug Use For Unknown Indication |
15.4% |
| Systemic Lupus Erythematosus |
15.4% |
| Hypertension |
13.5% |
| Pain |
5.8% |
| Product Used For Unknown Indication |
5.8% |
| Asthma |
3.8% |
| Gastritis Prophylaxis |
3.8% |
| Hypercholesterolaemia |
3.8% |
| Induced Abortion |
3.8% |
| Inferior Venacaval Thrombosis |
3.8% |
| Nephrotic Syndrome |
3.8% |
| Nephrotic Syndrome With Lesion Of Membranous Glomerulonephritis |
3.8% |
| Vena Cava Thrombosis |
3.8% |
| Atrial Fibrillation |
1.9% |
| Constipation |
1.9% |
| Hyperlipidaemia |
1.9% |
| Hyperuricaemia |
1.9% |
| Oedema Peripheral |
1.9% |
| Paradoxical Drug Reaction |
1.9% |
| Pulmonary Embolism |
1.9% |
|
| Ventricular Septal Defect |
18.2% |
| Death |
9.1% |
| Dermatitis Herpetiformis |
9.1% |
| Hyperkalaemia |
9.1% |
| Hyponatraemia |
9.1% |
| Hyposmia |
9.1% |
| Pulmonary Congestion |
9.1% |
| Renal Failure Acute |
9.1% |
| Upper Airway Obstruction |
9.1% |
| Vomiting |
9.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.4% |
| Hypertension |
17.8% |
| Spinal Osteoarthritis |
5.8% |
| Tachyarrhythmia |
5.1% |
| Product Used For Unknown Indication |
4.4% |
| Atrial Fibrillation |
4.1% |
| Chronic Obstructive Pulmonary Disease |
3.8% |
| Rheumatoid Arthritis |
3.1% |
| Pain |
2.8% |
| Coronary Artery Disease |
2.6% |
| Osteoporosis |
2.6% |
| Thrombosis Prophylaxis |
2.6% |
| Hyperlipidaemia |
2.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
| Pneumonia Aspiration |
2.0% |
| Cough |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Hypokalaemia |
1.8% |
| Sedation |
1.8% |
| Polyuria |
1.7% |
|
| Transaminases Increased |
14.3% |
| Suicide Attempt |
9.1% |
| Rhabdomyolysis |
7.8% |
| Toxic Epidermal Necrolysis |
7.8% |
| Tubulointerstitial Nephritis |
7.8% |
| Urine Colour Abnormal |
6.5% |
| Chest Pain |
5.2% |
| Hyponatraemia |
5.2% |
| Hypotension |
5.2% |
| Renal Failure Acute |
3.9% |
| Stevens-johnson Syndrome |
3.9% |
| Ventricular Septal Defect |
3.9% |
| Gastritis |
2.6% |
| Lung Infiltration |
2.6% |
| Swollen Tongue |
2.6% |
| Syncope |
2.6% |
| Thinking Abnormal |
2.6% |
| Umbilical Hernia |
2.6% |
| Visual Disturbance |
2.6% |
| Accidental Exposure To Product |
1.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.3% |
| Hypertension |
20.6% |
| Product Used For Unknown Indication |
17.3% |
| Prophylaxis |
5.2% |
| Diabetes Mellitus |
3.2% |
| Rheumatoid Arthritis |
3.1% |
| Atrial Fibrillation |
3.0% |
| Chronic Obstructive Pulmonary Disease |
2.9% |
| Non-small Cell Lung Cancer |
2.8% |
| Coronary Artery Disease |
2.5% |
| Cardiac Failure |
2.2% |
| Parkinson's Disease |
2.2% |
| Prophylaxis Against Transplant Rejection |
2.2% |
| Immunosuppression |
2.0% |
| Breast Cancer |
1.7% |
| Pain |
1.7% |
| Prostate Cancer |
1.7% |
| Depression |
1.6% |
| Myocardial Infarction |
1.5% |
| Thrombosis Prophylaxis |
1.4% |
|
| Vomiting |
8.7% |
| Hypertensive Crisis |
6.5% |
| Pneumonia |
6.5% |
| Pyrexia |
6.5% |
| General Physical Health Deterioration |
6.0% |
| Pulmonary Embolism |
6.0% |
| Renal Failure |
6.0% |
| Thrombocytopenia |
6.0% |
| Myocardial Infarction |
5.4% |
| Weight Decreased |
5.4% |
| Transaminases Increased |
4.9% |
| Urinary Tract Infection |
4.9% |
| Death |
3.8% |
| Pain |
3.8% |
| Necrosis |
3.3% |
| Pleural Effusion |
3.3% |
| Renal Failure Acute |
3.3% |
| Sepsis |
3.3% |
| Somnolence |
3.3% |
| Tachycardia |
3.3% |
|
| Interacting |
| Hypertension |
25.0% |
| Tachyarrhythmia |
17.6% |
| Rheumatoid Arthritis |
11.8% |
| Drug Use For Unknown Indication |
5.9% |
| Hyperlipidaemia |
5.9% |
| Immunosuppressant Drug Therapy |
5.9% |
| Iron Deficiency |
5.9% |
| Osteoporosis |
5.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.9% |
| Restlessness |
5.9% |
| Lung Transplant |
2.9% |
| Pneumocystis Jiroveci Pneumonia |
1.5% |
|
| Transaminases Increased |
57.1% |
| Drug Interaction |
14.3% |
| Hypotension |
14.3% |
| Reticulocytopenia |
14.3% |
|
